| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.69▲ | 3.72▼ | 3.73▼ | 3.61▲ | 3.39▲ |
| MA10 | 3.69▲ | 3.73▼ | 3.78▼ | 3.47▲ | 3.44▲ |
| MA20 | 3.72▼ | 3.76▼ | 3.63▲ | 3.36▲ | 3.75▼ |
| MA50 | 3.74▼ | 3.56▲ | 3.54▲ | 3.50▲ | 3.44▲ |
| MA100 | 3.77▼ | 3.52▲ | 3.40▲ | 3.86▼ | 3.25▲ |
| MA200 | 3.60▲ | 3.39▲ | 3.42▲ | 3.63▲ | 3.32▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.021▼ | -0.004▼ | 0.065▲ | -0.040▼ |
| RSI | 46.945▼ | 52.093▲ | 56.243▲ | 58.099▲ | 51.693▲ |
| STOCH | 43.680 | 27.306 | 30.523 | 69.588 | 29.606 |
| WILL %R | -51.852 | -83.544▼ | -52.381 | -38.889 | -46.552 |
| CCI | -19.553 | -109.155▼ | -30.792 | 181.730▲ | 60.638 |
|
Tuesday, January 26, 2021 04:54 PM
"This collaboration with Nelum is an exciting next step in our partnership strategy to broaden combinations and indications with our late stage checkpoint antibodies," said Julie DeSander, Vice ...
|
|
Tuesday, January 19, 2021 12:00 PM
LEXINGTON, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants ...
|
|
Tuesday, January 19, 2021 09:40 AM
Jan. 19, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/01/21 | 3.92 | 4.06 | 3.64 | 3.71 | 3,045,500 |
| 25/01/21 | 3.46 | 3.93 | 3.41 | 3.90 | 4,862,600 |
| 22/01/21 | 3.37 | 3.46 | 3.32 | 3.44 | 1,313,800 |
| 21/01/21 | 3.63 | 3.66 | 3.35 | 3.42 | 2,033,900 |
| 20/01/21 | 3.55 | 3.68 | 3.50 | 3.56 | 1,762,100 |
| 19/01/21 | 3.37 | 3.54 | 3.32 | 3.51 | 1,866,300 |
| 15/01/21 | 3.48 | 3.60 | 3.34 | 3.35 | 2,041,600 |
| 14/01/21 | 3.20 | 3.44 | 3.18 | 3.42 | 2,565,200 |
| 13/01/21 | 3.24 | 3.26 | 3.16 | 3.19 | 1,528,600 |
| 12/01/21 | 3.23 | 3.31 | 3.21 | 3.24 | 1,258,400 |
|
|
||||
|
|
||||
|
|